Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended July 3, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             .

 

Commission file number 1-3246

 


 

ProQuest Company

(Exact name of registrant as specified in its charter)

 


 

Delaware   36-3580106

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. employer

identification number)

300 North Zeeb Road, Ann Arbor, Michigan   48103-1553
(Address of principal executive offices)   (Zip code)

 

Registrant’s telephone number, including area code: (734) 761-4700

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by checkmark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).  x

 

The number of shares of the Registrant’s Common Stock, $.001 par value, outstanding as of August 9, 2004 was 28,478,730.

 



Table of Contents

TABLE OF CONTENTS

 

            

Page


PART I

  FINANCIAL INFORMATION     
   

Item 1.

  Consolidated Financial Statements     
       

Consolidated Statements of Operations for the Thirteen and Twenty-Six Week Periods Ended July 3, 2004 and June 28, 2003

   1
       

Consolidated Balance Sheets as of July 3, 2004, January 3, 2004 and June 28, 2003

   2
       

Consolidated Statements of Cash Flows for the Twenty-Six Week Periods Ended July 3, 2004 and June 28, 2003

   3
        Notes to the Consolidated Financial Statements    4
   

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations    15
   

Item 3.

  Quantitative and Qualitative Disclosures about Market Risk    27
   

Item 4.

  Controls and Procedures    27

PART II

  OTHER INFORMATION     
   

Item 1.

  Legal Proceedings    28
   

Item 4.

  Submissions of Matters to a Vote of Security Holders    28
   

Item 6.

  Exhibits and Reports on Form 8-K    28

SIGNATURE PAGE

   30

EXHIBITS

    

Certification of Chief Executive Officer - 302

   31

Certification of Chief Financial Officer - 302

   33

Certification of Chief Executive Officer - 906

   35

Certification of Chief Financial Officer - 906

   36


Table of Contents

ProQuest Company and Subsidiaries

Consolidated Statements of Operations

For the Thirteen and Twenty-Six Week Periods Ended July 3, 2004 and June 28, 2003

(In thousands, except per share data)

(Unaudited)

 

     Thirteen Weeks Ended

    Twenty-Six Weeks Ended

 
     July 3,
2004


    June 28,
2003


   

July 3,

2004


    June 28,
2003


 

Net sales

   $ 112,191     $ 110,705     $ 223,041     $ 218,268  

Cost of sales

     (56,319 )     (56,143 )     (111,332 )     (110,460 )
    


 


 


 


Gross profit

     55,872       54,562       111,709       107,808  

Research and development expense

     (4,083 )     (3,912 )     (8,482 )     (8,806 )

Selling and administrative expense

     (28,106 )     (28,439 )     (58,700 )     (55,831 )
    


 


 


 


Earnings from continuing operations before interest and income taxes

     23,683       22,211       44,527       43,171  

Net interest expense:

                                

Interest income

     628       235       888       406  

Interest expense

     (4,543 )     (4,679 )     (8,984 )     (9,384 )
    


 


 


 


Net interest expense

     (3,915 )     (4,444 )     (8,096 )     (8,978 )
    


 


 


 


Earnings from continuing operations before income taxes

     19,768       17,767       36,431       34,193  

Income tax expense

     (6,919 )     (6,396 )     (12,751 )     (12,310 )
    


 


 


 


Earnings from continuing operations

     12,849       11,371       23,680       21,883  

Earnings from discontinued operations, net (less applicable income taxes of $121, $515, $472 and $922, respectively)

     224       916       877       1,640  

Gain on sale of discontinued operations, net (less applicable income taxes of $515, $0, $515 and $0, respectively)

     15,338       —         15,338       —    
    


 


 


 


Net earnings

   $ 28,411     $ 12,287     $ 39,895     $ 23,523  
    


 


 


 


Net earnings per common share:

                                

Basic:

                                

Earnings from continuing operations

   $ 0.45     $ 0.41     $ 0.83     $ 0.78  

Earnings from discontinued operations

     0.01       0.03       0.03       0.06  

Gain on sale of discontinued operations

     0.54       —         0.54       —    
    


 


 


 


Basic net earnings per common share

   $ 1.00     $ 0.44     $ 1.40     $ 0.84  
    


 


 


 


Diluted:

                                

Earnings from continuing operations

   $ 0.45     $ 0.40     $ 0.82     $ 0.78  

Earnings from discontinued operations

     0.01       0.03       0.04       0.06  

Gain on sale of discontinued operations

     0.53       —         0.53       —    
    


 


 


 


Diluted net earnings per common share

   $ 0.99     $ 0.43     $ 1.39     $ 0.84  
    


 


 


 


Weighted average number of common shares and equivalents outstanding:

                                

Basic

     28,487       28,057       28,447       28,034  

Diluted

     28,782       28,319       28,797       28,155  

 

The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.

 

1


Table of Contents

ProQuest Company and Subsidiaries

Consolidated Balance Sheets

As of July 3, 2004, January 3, 2004 and June 28, 2003

(In thousands)

 

    

July 3,

2004
(Unaudited)


    January 3,
2004


    June 28,
2003
(Unaudited)


 

ASSETS

                        

Current assets:

                        

Cash and cash equivalents

   $ 8,573     $ 7,312     $ 3,263  

Accounts receivable, net

     82,261       94,242       79,224  

Inventory, net

     4,867       4,939       5,367  

Other current assets

     49,465       39,746       34,260  
    


 


 


Total current assets

     145,166       146,239       122,114  

Property, plant, equipment and product masters, at cost

     395,495       395,225       370,224  

Accumulated depreciation and amortization

     (204,148 )     (214,480 )     (192,320 )
    


 


 


Net property, plant, equipment and product masters

     191,347       180,745       177,904  

Long-term receivables

     5,735       5,106       4,775  

Goodwill

     297,457       303,693       267,642  

Identifiable intangibles, net

     13,567       9,435       7,773  

Purchased and developed software, net

     49,728       55,005       50,061  

Other assets

     18,248       23,813       31,317  
    


 


 


Total assets

   $ 721,248     $ 724,036     $ 661,586  
    


 


 


LIABILITIES AND SHAREHOLDERS’ EQUITY

                        

Current liabilities:

                        

Notes payable

   $ —       $ 300     $ —    

Accounts payable

     41,157       49,156       33,544  

Accrued expenses

     37,202       39,428       28,551  

Current portion of monetized future billings

     25,198       25,583       26,071  

Deferred income

     82,961       121,890       87,002  
    


 


 


Total current liabilities

     186,518       236,357       175,168  
    


 


 


Long-term liabilities:

                        

Long-term debt

     192,680       191,000       218,000  

Monetized future billings, less current portion

     43,432       46,835       48,254  

Other liabilities

     68,550       62,444       60,115  
    


 


 


Total long-term liabilities

     304,662       300,279       326,369  
    


 


 


Shareholders’ equity:

                        

Common stock ($.001 par value, 29,147 shares issued and 28,524 shares outstanding at July 3, 2004, 28,964 shares issued and 28,378 shares outstanding at January 3, 2004 and 28,840 shares issued and 28,283 shares outstanding at June 28, 2003)

     29       28       28  

Capital surplus

     314,267       310,461       307,546  

Unearned compensation on restricted stock

     (125 )     —         —    

Notes receivable for stock purchases

     (287 )     (279 )     (402 )

Retained earnings (accumulated deficit)

     (63,116